Skip to content

Greater omentum preserving operation for patients with cT1~T3 right-sided colon cancer : A prospective randomized controlled trial

Greater omentum preserving operation for patients with cT1~T3 right-sided colon cancer : A prospective randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104490
Enrollment
Unknown
Registered
2025-06-18
Start date
2026-01-07
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Right side Colon cancer

Interventions

Control group (Group A):Traditional laparoscopic radical resection of right-sided colon cancer
Experimental group (Group B):Laparoscopic radical resection of the right hemisphere of colon cancer with omentum preservation

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 78 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-78 years old; 2. Colorectal adenocarcinoma confirmed by colonoscopy and pathological biopsy; 3. Abdominal CT showed that the distal and proximal primary lesions were located in ileocecum and ascending colon; 4. The T stage of the tumor was less than or equal to 3 according to the imaging diagnosis at the time of initial treatment; 5. No abdominal metastasis was diagnosed by imaging at the time of initial treatment; 6. American Society of Anesthesiologists (ASA) score I-III; 7. Patients were able to understand the study protocol and willing to participate in the study, and provided written informed consent;

Exclusion criteria

Exclusion criteria: 1. Preoperative examination suggested synchronous multiple primary colorectal cancer or combined with other diseases requiring intestinal segment resection; 2. Preoperative imaging examination or intraoperative exploration indicated: 1) serosal or adjacent organ invasion (cT4) involving surrounding organs, 2) distant metastasis; 3) unable to perform R0 resection; 3. Previous history of colorectal cancer; 4. Patients who received preoperative neoadjuvant therapy; 5. History of other malignant tumors or familial adenomatous polyposis diagnosed within the past 5 years, except cured cervical carcinoma in situ, basal cell carcinoma, thyroid papillary carcinoma or skin squamous cell carcinoma; 6. Not suitable or intolerant to laparoscopic surgery; 7. Emergency surgery is needed when complicated with intestinal obstruction, intestinal perforation, intestinal bleeding, etc. 8. Patients with severe liver and kidney function, cardiopulmonary function, coagulation dysfunction or combined with serious underlying diseases can not tolerate surgery; 9. A history of severe mental illness; 10. Pregnant or lactating women; 11.MDT to discuss patients deemed ineligible for the study; 12. The patient could not understand the conditions and objectives of the study and refused to sign an informed colleague's letter;

Design outcomes

Primary

MeasureTime frame
3-year disease-free survival rate (DFS);

Secondary

MeasureTime frame
30-day perioperative complications;5-year overall survival rate (OS);

Countries

China

Contacts

Public ContactWang Meng; Zhu Yuping

Zhejiang Cancer Hospital

wangmeng@zjcc.org.cn+86 571 88128012

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026